Serial MRD Assessment in Medulloblastoma Liquid Biopsies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Serial assessment of measurable residual disease in medulloblastoma liquid biopsies
Cancer Cell 2021 Nov 08;39(11)1519-1530.e4, APY Liu, KS Smith, R Kumar, L Paul, L Bihannic, T Lin, KK Maass, KW Pajtler, M Chintagumpala, JM Su, E Bouffet, MJ Fisher, S Gururangan, R Cohn, T Hassall, JR Hansford, P Klimo, FA Boop, CF Stewart, JH Harreld, TE Merchant, RG Tatevossian, G Neale, M Lear, JM Klco, BA Orr, DW Ellison, RJ Gilbertson, A Onar-Thomas, A Gajjar, GW Robinson, PA NorthcottFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.